Trial of Gene Therapy to Treat Sickle Cell Disease Reports Initial Positive Results

Cleveland Clinic·Aug 24

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A trial of gene therapy to treat sickle cell disease has reported initial positive results. The therapy has shown success in treating severe cases of the disease, with one participant reportedly freed from symptoms. The development is part of ongoing research into gene editing and therapy for sickle cell disease, with various institutions and studies contributing to the field.

Full coverage

FDA approves gene therapy for children with sickle cell disease ages 2+

WKRN News 2·23h ago

What a decade of gene therapy research for sickle cell disease taught UCLA scientists

Newsroom | UCLA·Apr 20

Fetching the latest headlines…

Trial of Gene Therapy to Treat Sickle Cell Disease Reports Initial Positive Results

Full coverage

FDA approves gene therapy for children with sickle cell disease ages 2+

What a decade of gene therapy research for sickle cell disease taught UCLA scientists

Gene-editing therapy frees first trial participant from SCD symptoms

Columbia Tests New Gene Therapies for Sickle Cell

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Gene editing therapy shows success against severe sickle cell disease

Sickle cell anemia: What’s new and what’s next

Rewriting the Hemoglobin Switch: CRISPR Targeting in Sickle Cell Disease